Get started
Author

Alicia de Luna Aguilar

Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis
2023 · Javier David Benitez Fuentes, Eileen Morgan, et al. · JAMA Oncology · 274
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
2022 · Javier David Benitez Fuentes, Kauzar Mohamed Mohamed, et al. · Frontiers in Oncology · 33
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
2024 · Javier David Benitez Fuentes, Jorge Bartolome Arcilla, et al. · Cancers · 18
PDF
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors
2023 · Jesús Fuentes-Antrás, Ana Martínez-Rodríguez, et al. · International Journal of Molecular Sciences · 17
PDF
Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis
2025 · Javier David Benitez Fuentes, Jorge Bartolome Arcilla, et al. · Frontiers in Oncology · 10
Potential Negative Impacts of the CCI4EU Initiative on Spain
2024 · Javier David Benitez Fuentes, Asia Ferrandez Arias, et al. · JCO Global Oncology · 7
PDF
Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study
2023 · Alicia Milagros de Luna Aguilar, Javier David Benitez Fuentes, et al. · Cancers · 4
PDF
Revisiting Alma Ata: A Blueprint for Cancer Care
2025 · Javier-David Benitez-Fuentes, Rodrigo Lastra del Prado, et al. · Cancer Control · 3
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain
2022 · Javier David Benitez Fuentes, Alicia de Luna Aguilar, et al. · F1000Research · 3
PDF
Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square · 2
Case Report: Bocavirus Infection Radiologically Resembling a Congestive Heart Failure in a Patient with Metastatic Castration-Resistant Prostate Cancer
2022 · Javier David Benitez Fuentes, Alicia de Luna Aguilar, et al. · F1000Research · 2
PDF
Geographic access as a modifiable determinant of cancer care: perspectives on hub-and-spoke oncology networks, travel burden and time toxicity
2026 · Javier-David Benitez-Fuentes, Alicia de Luna Aguilar, et al. · Clinical & Translational Oncology · 1
Adverse drug reactions of the SARS-CoV-2 mRNA-1273 vaccine in a cohort of cancer patients of a tertiary hospital in Madrid, Spain.
2022 · Alejandro Francisco Jiménez Ortega, Alicia de Luna Aguilar, et al. · Journal of Clinical Oncology · 1
Territorial inequality in oncology clinical trial participation and its ecological association with cancer mortality in Spain
2026 · Antonio David Lázaro-Sánchez, Mahsa Fayaz Dastgerdi, et al. · Journal of Cancer Policy
Oncology with common sense: beyond biologistic and pharmacological models
2026 · Rodrigo Lastra, Patricia Iranzo, et al. · ecancermedicalscience
PDF
Paying for Convenience in Universal Health Coverage: A European Perspective
2025 · Javier David Benítez Fuentes, Alicia de Luna Aguilar · JCO Oncology Practice
Abstract P1-06-19: Circulating Cytokine Profiles Associated with Differential Stromal Tumor Infiltrating Lymphocyte (sTIL) Levels in ER-positive Early Breast Cancer
2025 · Noel Blaya Boluda, Esmeralda García-Torralba, et al. · Clinical Cancer Research
Abstract P4-11-16: Improvement of Pathologic Complete Response Prediction with Plasma Cytokine Profiles in Hormone Receptor-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy
2025 · Noel Blaya Boluda, Esmeralda García-Torralba, et al. · Clinical Cancer Research
Reply to: Correction Regarding Commentary “Comprehensive Cancer Infrastructures for the European Union—Coordination and Support Action—CCI4EU CSA”
2025 · Javier David Benitez Fuentes, Asia Ferrández-Arias, et al. · JCO Global Oncology
Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square
PDF
Continuing cyclin dependent kinase 4/6 inhibition with abemaciclib in metastatic breast cancer patients previously treated with palbociclib or ribociclib: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square
202P Abemaciclib in HR+/Her2- metastatic breast cancer patients after previous progression on palbociclib or ribociclib: Clinical experience in a tertiary hospital in Madrid, Spain
2022 · A. De Luna Aguilar, F. Moreno Anton, et al. · Annals of Oncology
CLO22-047: Outcomes of SARS-COV-2 mRNA-1273 Vaccine in Cancer Patients: Seroconversion and Adverse Events
2022 · Javier David Benitez Fuentes, Alicia de Luna Aguilar, et al. · Journal of the National Comprehensive Cancer Network
Works count: 23
Citation count: 375
H-index: 6
I10-index: 5
Year
Topic
Type